Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

At the forefront of advanced and holistic treatments, Mount Elizabeth Hospital uses a comprehensive team approach in treatments.

Research at City of Hope reveals how common white button mushrooms might enhance prostate cancer treatment through surprising ...

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

Treatment uses electric pulses to kill prostate cancer cells while minimising risks of incontinence and sexual dysfunction.

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...